Skip to main content
Journal cover image

Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver.

Publication ,  Journal Article
Marin, D; Catalano, C; Rossi, M; Guerrisi, A; Di Martino, M; Berloco, P; Passariello, R
Published in: J Magn Reson Imaging
September 2008

We report a case of histologically proven primary leiomyoma of the liver that was evaluated with multiphasic 64-section computed tomography (CT) and gadobenate dimeglumine-enhanced magnetic resonance (MR) imaging. This lesion showed vivid enhancement during the arterial phase with sustained enhancement during the hepatic venous and equilibrium phases. During the liver-specific MR imaging phase (150 minutes after contrast injection), the same lesion demonstrated lack of contrast retention, thus appearing hypointense compared with the background liver. Because of this latter finding, the patient underwent partial resection of the liver. In primary hepatic leiomyoma, the absence of contrast uptake during the liver-specific phase of gadobenate dimeglumine-enhanced MR imaging may be inappropriately interpreted as a sign of malignancy, thus leading to unnecessary, aggressive management of such lesions.

Duke Scholars

Published In

J Magn Reson Imaging

DOI

ISSN

1053-1807

Publication Date

September 2008

Volume

28

Issue

3

Start / End Page

755 / 758

Location

United States

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Magnetic Resonance Imaging
  • Liver Neoplasms
  • Leiomyoma
  • Image Enhancement
  • Humans
  • Gadolinium DTPA
  • Female
  • Contrast Media
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Marin, D., Catalano, C., Rossi, M., Guerrisi, A., Di Martino, M., Berloco, P., & Passariello, R. (2008). Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver. J Magn Reson Imaging, 28(3), 755–758. https://doi.org/10.1002/jmri.21519
Marin, Daniele, Carlo Catalano, Massimo Rossi, Antonino Guerrisi, Michele Di Martino, Pasquale Berloco, and Roberto Passariello. “Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver.J Magn Reson Imaging 28, no. 3 (September 2008): 755–58. https://doi.org/10.1002/jmri.21519.
Marin D, Catalano C, Rossi M, Guerrisi A, Di Martino M, Berloco P, et al. Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver. J Magn Reson Imaging. 2008 Sep;28(3):755–8.
Marin, Daniele, et al. “Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver.J Magn Reson Imaging, vol. 28, no. 3, Sept. 2008, pp. 755–58. Pubmed, doi:10.1002/jmri.21519.
Marin D, Catalano C, Rossi M, Guerrisi A, Di Martino M, Berloco P, Passariello R. Gadobenate dimeglumine-enhanced magnetic resonance imaging of primary leiomyoma of the liver. J Magn Reson Imaging. 2008 Sep;28(3):755–758.
Journal cover image

Published In

J Magn Reson Imaging

DOI

ISSN

1053-1807

Publication Date

September 2008

Volume

28

Issue

3

Start / End Page

755 / 758

Location

United States

Related Subject Headings

  • Nuclear Medicine & Medical Imaging
  • Middle Aged
  • Magnetic Resonance Imaging
  • Liver Neoplasms
  • Leiomyoma
  • Image Enhancement
  • Humans
  • Gadolinium DTPA
  • Female
  • Contrast Media